True North Advisors’s Organon & Co OGN Stock Holding History

True North Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,772	Closed	-$158K	–	266
2025 Q3	$158K	Buy	+14,772	New	+$145K	0.03%	212

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

KBG

Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

True North Advisors's OGN Position: Q4 2025 in Review

True North Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 14,772 shares — an estimated $158K sold.

True North Advisors first reported a position in OGN in Q3 2025 and held it in 1 quarter. The position peaked at $158K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

True North Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
True North Advisors sold 14,772 Organon & Co shares in Q4 2025, an estimated $158K.
True North Advisors first reported a position in Organon & Co in Q3 2025 and held it in 1 quarter.
True North Advisors's Organon & Co position peaked at $158K in Q3 2025.
634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on True North Advisors's 13F filing for Q4 2025, filed 22 Jan 2026.